Breaking News

Tweet TWEET

EnWave Signs Agency Agreement with CD Process LLC

EnWave Signs Agency Agreement with CD Process LLC 
VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 11/05/13 -- EnWave
Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave", or the
"Company") announced today that it has signed an Agency Agreement
(the "Agreement") with CD Process LLC ("CD"), a North American-based
technology company that addresses the ingredient processing
requirements of the global food industry. This Agreement broadens
EnWave's sales network for Radiant Energy Vacuum ("REV(TM)")
technology by partnering with a business entity comprised of several
food industry veterans that have extensive technology, research &
development and sales & marketing expertise. Furthermore, due to a
very close working relationship with EnWave, CD's key personnel have
a high level of experience and proficiency working with REV(TM)
technology. 
CD will actively pursue commercial opportunities for REV(TM)
technology by utilizing their existing network of food industry
contacts. They also have access to nutraREV(R) technology to conduct
product development work for a number of potential clients throughout
the United States of America. The end goal of CD is to eventually
establish a centralized toll processing facility, including licensed
REV(TM) technology for specific applications, to service a number of
clients in the food and nutraceutical industries. All other details
of the Agreement are confidential.  
"The management of CD Process is extremely qualified to work as an
extension of our business development efforts," stated Dr. Tim
Durance, Chairman and Co-CEO of EnWave. "It is EnWave's immediate
goal to significantly increase its agent and sales network in order
to increase the commercialization of REV(TM) technology in several
established market sectors including meat, cheese, fruit, vegetables,
enzymes and spice product areas." 
About CD Process LLC  
Based in the Midwest of the United States of America, CD Process is a
food processing company set up to serve the ingredient processing
requirements of the food industry. With their proprietary
technologies they can dehydrate and, if required, can particle size
reduce food ingredients whilst retaining a high nutritional content
within the ingredients. This is achieved because they can dehydrate
at lower temperatures than conventional methods. Their technologies
can also produce unique textures not possible through traditional
methods. For more information on CD Process please visit
www.cdprocess.com. 
About EnWave  
EnWave Corporation is a Vancouver-based industrial technology company
developing commercial applications for its proprietary Radiant Energy
Vacuum (REV(TM)) dehydration technology. In June 2013, Hormel Foods
Corporation signed a royalty-bearing commercial license to use
REV(TM) technology for the production of a number of products.
Recently, EnWave formed a Limited Liability Partnership with Lucid
Capital Management to develop, manufacture, market and sell
all-natural cheese snack products in the United States. Also, the
Company has licensed REV(TM) technology to a leading North American
enzyme company to begin dehydrating a series of food-related enzymes
for their Tier 1 customers. Lastly, the company licensed REV(TM)
technology to Milne Fruit Products Inc in 2011, its first major U.S.
customer, to support a launch of healthy berry snacks and powders
across most major markets in North America. EnWave has entered into a
wide range of research and collaboration agreements with an expanding
list of multinational companies, including Nestle, Kellogg's, Grupo
Bimbo, Grimmway Farms, Ocean Spray Cranberries, Bonduelle, Cherry
Central, Sun-Maid Growers, Gay Lea Foods and Merck. EnWave is
introducing REV(TM) as a new dehydration standard in the food and
biological material sectors: potentially faster and cheaper than
freeze drying, with better end product quality than air drying or
spray drying. 
EnWave currently has six REV(TM) platforms: commercial-scale
nutraREV(R) and MIVAP(R) are used in the food industry to dry fruits,
vegetables, meat, herbs and seafood quickly and at low-cost, while
maintaining high levels of nutrition, taste, texture and colour. The
Company is also developing powderREV(TM) for bulk dehydration of food
cultures, probiotics and fine biochemicals such as enzymes;
quantaREV(TM) for continuous, high-volume low-temperature drying of
pastes, gels, liquids, or particulates; and bioREV(TM) and
freezeREV(TM) as new methods to stabilize and dehydrate
biopharmaceuticals such as vaccines and antibodies. More information
about EnWave is available at www.enwave.net.  
EnWave Corporation  
Dr. Tim Durance, Chairman & Co-CEO 
Safe Harbour for Forward-Looking Information Statements: This press
release may contain forward-looking information based on management's
expectations, estimates and projections. All statements that address
expectations or projections about the future, including statements
about the Company's strategy for growth, product development, market
position, expected expenditures, and the expected synergies following
the closing are forward-looking statements. All third party
references to market information in this release are not guaranteed
to be accurate as the Company did not conduct the original primary
research. These statements are not a guarantee of future performance
and involve a number of risks, uncertainties and assumptions.
Although the Company has attempted to identify important factors that
could cause actual results to differ materially, there may be other
factors that cause results not to be as anticipated, estimated or
intended. There can be no assurance that such statements will prove
to be accurate, as actual results and future events could differ
materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward-looking
statements. 
Neither the TSX Venture Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
Contacts:
EnWave Corporation
Mr. John McNicol
President & Co-CEO
(604) 601-8524
john.mcnicol@enwave.net 
EnWave Corporation
Mr. Brent Charleton
Vice President, Corporate Affairs
(778) 378-9616
bcharleton@enwave.net
www.enwave.net
 
 
Press spacebar to pause and continue. Press esc to stop.